Antonio Giordano, Clinical Director at Dana-Farber Cancer Institute, shared on X:
“Why do DXd-ADCs cause ILD regardless of target?
ILD tracks with the DXd payload + IgG1 backbone — HER2, TROP2, HER3 alike. It’s OFF-target, not on-target/off-tumor. Dr. Vamsi Velcheti.”

Discover more:
ADC-Related Interstitial Lung Disease: A Class-Relevant Toxicity That Requires Early Recognition